The 5 analysts offering 12-month price forecasts for Sio Gene Therapies Inc have a median target of 8.00, with a high estimate of 10.00 and a low estimate of 6.00. The median estimate represents a +403.14% increase from the last price of 1.59.
The current consensus among 5 polled investment analysts is to Buy stock in Sio Gene Therapies Inc. This rating has held steady since October, when it was unchanged from a Buy rating.Move your mouse over past months for detail
Earnings and Sales Forecasts
Earnings per Share -$0.20
Reporting Date Feb 08
Earnings per Share
Move your mouse over a quarter or year to see how estimates have changed over time.